Receptor binding activities of Chlorella on cysteinyl leukotriene CysLT, glutamate AMPA, ion channels, purinergic P2Y, tachykinin NK 2 receptors and adenosine transporter

Phytotherapy Research

Volumn 24, Issue 1, 2010, Pages 43-48

  Cheng, Fong Chi ^a   Feng, Jin Jye ^a   Chen, Kuo Hsin ^a   Imanishi, Hideyo ^a   Fujishima, Masaki ^b   Takekoshi, Hideo ^b   Naoki, Yo ^b   Shimoda, Minoru ^c  

^a MDS Pharma Services   (Taiwan)

^b Sun Chlorella Corp   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chlorella; Glutamate; Ion channels; Leukotriene; Purinergic P2Y; Receptors; Serotonin 5HT2B; Tachykinin NK2; Transporter

Indexed keywords

ADENOSINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BENZOTHIAZEPINE DERIVATIVE; CALCIUM CHANNEL L TYPE; CALCIUM ION; CHLORELLA EXTRACT; GABAPENTIN; GLYCINE; INOSITOL TRISPHOSPHATE 3 KINASE; ION CHANNEL; KAINIC ACID; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE C4; LEUKOTRIENE D4 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NEUROKININ 2 RECEPTOR; PEPTIDOLEUKOTRIENE; PROSTANOID RECEPTOR; PURINERGIC P2Y RECEPTOR; SEROTONIN 2B RECEPTOR; THROMBOXANE A2 RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHLORELLA; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MODULATION; NONHUMAN; RAT;

ANIMALS; CELL LINE, TUMOR; CHLORELLA; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HUMANS; INHIBITORY CONCENTRATION 50; ION CHANNELS; MALE; NUCLEOSIDE TRANSPORT PROTEINS; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, LEUKOTRIENE; RECEPTORS, NEUROTRANSMITTER;

EID: 74249089246     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2864     Document Type: Article

References (47)

1. 2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58: 281-341.
2. Arnold LM, Goldenberg DL, Stanford SB et al. 2007. Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 56: 1336-1344.
3. 2B receptor antagonist in vitro and in vivo. Br J Pharmacol 143: 549-560.
4. Bezprozvanny I. 2005. The inositol 1,4,5-trisphosphate receptors. Cell Calcium 38: 261-270.
5. Boison D. 2005. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 11: 25-36.
6. Borman RA, Tilford NS, Harmer DW et al. 2002. 5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro. Br J Pharmacol 135: 1141-1151.
7. 2Y-purinergic receptor. J Biol Chem 265: 13515-13520.
8. Brink C, Dahlen SE, Drazen J et al. 2003. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol Rev 55: 195-227.
9. Capra V, Ambrosio M, Riccioni G, Rovati GE. 2006. Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities. Curr Med Chem 13: 3213-3226.
10. Chen X, Wang S, Wu N, Yang CS. 2004. Leukotriene A4 hydrolase as a target for cancer prevention and therapy. Curr Cancer Drug Targets 4: 267-283.
11. Cheng FC, Lin A, Feng JJ et al. 2004. Effects of Chlorella on activities of protein tyrosine phosphatases, matrix metal-loproteinases, caspases, cytokine release, B and T cell proliferations, and phorbol ester receptor binding. J Med Food 7: 146-152.
12. Derkach VA, Oh MC, Guire ES, Soderling TR. 2007. Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nat Rev Neurosci 8: 101-113.
13. Dingledine R, Borges K, Bowie D, Traynelis SF. 1999. The glutamate receptor ion channels. Pharmacol Rev 51: 7-61.
14. Dogné J-M, Hanson J, de Leval X et al. 2006. From the design to the clinical application of thromboxane modulators. Curr Pharm Design 12: 903-923.
15. 2 receptors in human platelets. J Pharmacol Exp Ther 245: 786-792.
16. Honore T, Lauridsen J, Krogsgaard-Larsen P. 1982. The binding of tritium labeled RS-alpha amino-3-hydroxy-5-methylisoxazole-4-propionic acid: a structural analog of glutamic-acid to rat brain membranes. J Neurochem 38: 173-178.
17. Hsiuan-Lin W, Ruey-Shyang, H, Liang-Ping, L. 2001. Identification of Chlorella spp. isolates using ribosomal DNA sequences. Bot Bull Acad Sin 42: 115-121.
18. Inoue K, Mukaiyama Y, Oka H, Misawa H. 1995. Clinical effects of Chlorella in hypertensive men. J Jpn Soc Nutr Food Sci 48: 485-489.
19. Kanouchi H, Okabe M, Doi S, Yamada H, Tachibana H, Yamada K. 2001. Dietary effect of Chlorella pyrenoidosa powder on immunoglobulin productivity of Sprague-Dawley rats. Nippon Shokuhin Kagaku Kaishi 48: 634-636.
20. Komiyama K, Hirokawa Y, Morota T, Umezawa I. 1986. Antitumor activity and immunological response. Chemotherapy 32: 302-307.
21. Konishi F, Tanaka K, Himeno K, Taniguchi K, Nomoto K. 1985. Antitumor effect induced by a hot water extract of Chlorella vulgaris (CE): resistance to Meth-A tumor growth mediated by CE-induced polymorphonuclear leukocytes. Cancer Immunol Immunother 19: 73-78.
22. 2 receptors in human. Auton Neurosci 126-127: 232-249.
23. 3H]kainic acid to receptor sites in rat brain. Mol Pharmacol 15: 492-505.
24. Mason R. 2001. Chlorella and Spirulina: Green supplements for balancing the body. Altern Complement Ther 7: 161-165.
25. Merchant RE, Andre CA. 2001. A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis. Altern Ther Health Med 7: 79-91.
26. Miriam MA, Laia TM, Javier CF, Marcal PA. 2008. Physiological and pharmacological roles of nucleoside transporter proteins. Nucleosides, Nucleotides Nucleic Acids 27: 769-778.
27. Miyazawa Y, Murayama T, Ooya N, Wang LF, Tung YC, Yamaguchi N. 1988. Immunomodulation by a unicellular green algae ( Chlorella pyrenoidosa) in tumor-bearing mice. J Ethnopharmacol 24: 135-146.
28. Morita K, Matsueda T, Iida T. 1997. Effects of Chlorella, spirulina and chlorophyllin on fecal excretion of polychloronated dibenzop-dioxins in rats. Jpn J Toxicol Environ Health 43: 42-47.
29. Murakami T, Iiduka Y, Okamoto K, Oogaki M. 1987. Effect of Chlorella on blood pressure, cerebral stroke lesions, hypertensive vascular changes and life-span in spontaneously hypertensive rats. J Jpn Soc Nutr Food Sci 40: 351-359.
30. Nakano S, Takekoshi H, Nakano M. 2006. Chlorella ( Chlorella pyrenoidosa) supplementation decreases dioxane and increases immunoglobin A concentrations in breast milk. J Med Food 10: 134-142.
31. Nothacker HP, Wang Z, Zhu Y, Reinscheid RK, Lin SH, Civelli O. 2000. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. Mol Pharmacol 58: 1601-1608.
32. Patacchini R, Maggi CA. 1995. Tachykinin receptors and receptor subtypes. Arch Int Pharmacodyn 329: 161-184.
33. Rao VR, Finkbeiner S. 2007. NMDA and AMPA receptors: old channels, new tricks. Trends Neurosci 30: 284-291.
34. Robertson RM, Robertson D. 1996. Chapter 32: Drugs used for the treatment of myocardial ischemia. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill: New York, 759-779.
35. Rodríguez-López M, López-Quijada C. 1971. Plasma glucose and plasma insulin in normal and alloxanized rats treated with Chlorella. Life Sci 10: 57-60.
36. 3H]Diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex. Eur J Pharmacol 111: 273-277.
37. Shibata S, Orita K, Iwabuchi A, Misawa H. 1998. Serum cholesterol lowering action of hardly digestible fraction of chlorella. J Jpn Soc Nutr Food Sci 52: 100.
38. 3H]MDL 105,519 to homomeric NMDA-NR1a receptors. Eur J Pharmacol 312: 357-365.
39. 3H]gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur J Pharmacol 244: 293-301.
40. Takekoshi H, Mizoguchi T, Komasa Y et al. 2005a. Suppression of glutathione S-transferase placental form - positive foci development in rat hepatocarcinogenesis by Chlorella pyrenoidosa. Oncol Rep 14: 409-414.
41. Takekoshi H, Suzuki G, Chubachi H, Nakano M. 2005b. Effect of Chlorella pyrenoidosa on fecal excretion and liver accumulation of polychlorinated dibenzo-p-dioxin in mice. Chemosphere 59: 297-304.
42. Tanaka K, Koga T, Konishi F et al. 1986. Augmentation of host defense by a unicellular green alga. Chlorella vulgaris, to Escherichia coli infection. Infect Immun 53: 267-271.
43. Tanaka K, Konishi F, Himeno K, Taniguchi K, Nomoto K. 1984. Augmentation of antitumor resistance by a strain of unicellular green algae, Chlorella vulgaris. Cancer Immunol Immunother 17: 90-94.
44. Verma A, Marangos PJ. 1985. Nitrobenzylthioinosine binding in brain: an interspecies study. Life Sci 36: 283-290.
45. Ward DT. 2004. Calcium receptor-mediated intracellular signaling. Cell Calcium 35: 217-228.
46. 4-induced homologous desensitization of calcium mobilization and phosphoinositide metabolism in U-937 cell. J Pharmacol Exp Ther 246: 204-210.
47. Worley PF, Baraban JM, Supattapone S, Wilson VS, Snyder SH. 1987. Characterization of inositol triphosphate receptor binding in brain. J Biol Chem 262: 12132-12136.